Overweight and obesity are highly prevalent in developed countries and are also becoming
more frequent in the developing world. Overweight and obese patients have elevated levels …

Background Inflammation and endothelial dysfunction are associated with morbid obesity
(MO) and atherosclerosis. Objective To evaluate inflammation and endothelial function as …

Background and aims Obesity without metabolic alterations (Metabolically Healthy Obesity,
MHO) is a condition with a risk of death and cardiovascular disease lower than that of …

Background Obesity has been linked with a chronic state of inflammation which may be
involved in the development of metabolic syndrome, cardiovascular disease, non-alcoholic …

Background Obesity and obesity-associated type 2 diabetes mellitus (T2DM) are frequently
related to a low-grade chronic inflammatory state, which increases the risk of developing …

Background: Morbidly obese patients are at risk of developing insulin resistance and
cardiovascular disease. Low-grade systemic inflammation is an important factor for this …

Background Systemic inflammation is a hallmark of obesity as well as of other chronic
diseases, usually indicating increased cardiovascular risk; however, studies with arterial …

Introduction Obesity is a chronic disease responsible for a high morbidity and mortality rate,
with an increasing worldwide prevalence. Obesity is associated with immune responses …

Background: Obesity is a worldwide pandemic that causes a multitude of co-morbid
conditions. However, there has been slow progress in understanding the basic …

Two billion people worldwide older than 18 years of age, or approximately 30% of the world
population, are overweight or obese. In addition, more than 43 million children under the …